Product Description

Pyrazolam 3mg

Pyrazolam 3mg is a synthetic benzodiazepine derivative (specifically a thienotriazolodiazepine) developed in the early 2010s. It is classified as a novel psychoactive substance (NPS) or research chemical and is not approved for medical use in any major jurisdiction, including the US, UK, or EU. A 3mg dose is considered a strong/common recreational or anxiolytic dose according to user reports.

Pharmacology

Pyrazolam acts as a positive allosteric modulator of the GABA-A receptor, primarily with high affinity for the α2 and α5 subunits. It produces strong anxiolytic (anti-anxiety) effects with reportedly less sedation and muscle relaxation compared to traditional benzodiazepines like alprazolam or diazepam.

• Onset (oral): 30–60 minutes
• Peak: 2–4 hours
• Duration: 6–10 hours (some users report longer after-effects)

It is known for producing a relatively “clear-headed” anxiolytic effect, which has made it popular in certain research chemical communities.

Acute Safety Profile

Pyrazolam is a potent benzodiazepine. At 3mg, users commonly report:

• Significant anxiety reduction
• Mild to moderate sedation
• Muscle relaxation
• Mild euphoria in some cases

Common Side Effects:

• Drowsiness and fatigue
• Dizziness and coordination impairment
• Memory impairment (anterograde amnesia)
• Dry mouth
• Next-day grogginess (“benzo hangover”)

Serious Risks:

• Respiratory depression (especially when combined with alcohol, opioids, or other depressants)
• High potential for tolerance, dependence, and withdrawal
• Rebound anxiety and insomnia after discontinuation
• Risk of seizures during abrupt withdrawal after prolonged use

Toxicity & Dependence

Like other benzodiazepines, Pyrazolam carries a substantial risk of physical and psychological dependence. Regular use, even for a few weeks, can lead to withdrawal symptoms that may be severe. There is very limited clinical safety data on Pyrazolam specifically, as it has never undergone full human clinical trials for medical approval.

Drug Interactions & Contraindications

• High Risk: Alcohol, opioids, other benzodiazepines, gabapentinoids, or any CNS depressants (can cause dangerous respiratory depression or overdose).
• Contraindicated for individuals with respiratory conditions, history of substance dependence, severe depression, or liver impairment.
• Not recommended during pregnancy or breastfeeding.

Legal Status (as of 2026)

Pyrazolam is controlled or banned in many countries (including the UK under the Psychoactive Substances Act, and several EU nations). In the US, it exists in a legal gray area but is generally considered illegal for human consumption.